✦ LIBER ✦

PCV1 AN ECONOMIC EVALUATION OF CLOPIDOGREL IN SECONDARY PREVENTION OF ISCHEMIC EVENTS: HIGH RISK POPULATIONS

✍ Scribed by E Levy; S Gabriel; P Carita; J Dinet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV6 AN ECONOMIC EVALUATION OF CLOPIDOGR

✍ G Rudelli; L Annemans; J Spiesser; M Novelli; A Walker; S Gabriel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

CV6 AN ECONOMIC EVALUATION OF CLOPIDOGRE

✍ Annemans, L; Gabriel, S; Spiesser, J; Vranckx, K; De Knock, M; Carita, P 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV31 ECONOMIC EVALUATION OF CLOPIDOGREL

✍ K Borsos; J Nagy; E Belicza; J Spiesser; S Gabriel; G Blaskó 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCV30 PROBABILISTIC SENSITIVITY ANALYSIS

✍ X Lennes; P Carita; S Gabriel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCV5: ECONOMIC EVALUATION OF RAMIPRIL IN

✍ ME Backhouse; A Richter; L Gaffney 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Clopidogrel added to aspirin versus aspi

✍ Deepak L. Bhatt; Eric J. Topol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB